vs

Side-by-side financial comparison of Emerald Holding, Inc. (EEX) and PUMA BIOTECHNOLOGY, INC. (PBYI). Click either name above to swap in a different company.

Emerald Holding, Inc. is the larger business by last-quarter revenue ($132.7M vs $75.5M, roughly 1.8× PUMA BIOTECHNOLOGY, INC.). On growth, PUMA BIOTECHNOLOGY, INC. posted the faster year-over-year revenue change (27.7% vs 24.3%). PUMA BIOTECHNOLOGY, INC. produced more free cash flow last quarter ($14.4M vs $11.7M). Over the past eight quarters, PUMA BIOTECHNOLOGY, INC.'s revenue compounded faster (31.3% CAGR vs -0.3%).

TVS Emerald Haven Realty Limited is an Indian real estate development company headquartered in Chennai, Tamil Nadu. A subsidiary of TVS Holdings, it specializes in sustainable residential communities and urban development projects.

Puma Biotechnology is a publicly traded biopharmaceutical company headquartered in Los Angeles, CA.

EEX vs PBYI — Head-to-Head

Bigger by revenue
EEX
EEX
1.8× larger
EEX
$132.7M
$75.5M
PBYI
Growing faster (revenue YoY)
PBYI
PBYI
+3.5% gap
PBYI
27.7%
24.3%
EEX
More free cash flow
PBYI
PBYI
$2.7M more FCF
PBYI
$14.4M
$11.7M
EEX
Faster 2-yr revenue CAGR
PBYI
PBYI
Annualised
PBYI
31.3%
-0.3%
EEX

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
EEX
EEX
PBYI
PBYI
Revenue
$132.7M
$75.5M
Net Profit
$-30.2M
Gross Margin
69.3%
Operating Margin
-11.8%
22.7%
Net Margin
-22.8%
Revenue YoY
24.3%
27.7%
Net Profit YoY
-692.2%
EPS (diluted)
$-0.15
$0.26

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
EEX
EEX
PBYI
PBYI
Q4 25
$132.7M
$75.5M
Q3 25
$77.5M
$54.5M
Q2 25
$105.5M
$52.4M
Q1 25
$147.7M
$46.0M
Q4 24
$106.8M
$59.1M
Q3 24
$72.6M
$80.5M
Q2 24
$86.0M
$47.1M
Q1 24
$133.4M
$43.8M
Net Profit
EEX
EEX
PBYI
PBYI
Q4 25
$-30.2M
Q3 25
$-14.4M
$8.8M
Q2 25
$-1.4M
$5.9M
Q1 25
$15.3M
$3.0M
Q4 24
$5.1M
Q3 24
$-11.1M
$20.3M
Q2 24
$-2.8M
$-4.5M
Q1 24
$11.0M
$-4.8M
Gross Margin
EEX
EEX
PBYI
PBYI
Q4 25
69.3%
Q3 25
77.7%
Q2 25
76.5%
Q1 25
77.1%
Q4 24
76.4%
Q3 24
63.9%
Q2 24
77.4%
Q1 24
75.5%
Operating Margin
EEX
EEX
PBYI
PBYI
Q4 25
-11.8%
22.7%
Q3 25
-10.1%
17.6%
Q2 25
9.7%
12.7%
Q1 25
24.2%
8.7%
Q4 24
19.5%
22.6%
Q3 24
-6.5%
27.4%
Q2 24
7.4%
-4.6%
Q1 24
18.2%
-5.3%
Net Margin
EEX
EEX
PBYI
PBYI
Q4 25
-22.8%
Q3 25
-18.6%
16.2%
Q2 25
-1.3%
11.2%
Q1 25
10.4%
6.5%
Q4 24
4.8%
Q3 24
-15.3%
25.2%
Q2 24
-3.3%
-9.6%
Q1 24
8.2%
-11.0%
EPS (diluted)
EEX
EEX
PBYI
PBYI
Q4 25
$-0.15
$0.26
Q3 25
$-0.07
$0.17
Q2 25
$-0.01
$0.12
Q1 25
$0.08
$0.06
Q4 24
$0.01
$0.40
Q3 24
$-0.05
$0.41
Q2 24
$-0.03
$-0.09
Q1 24
$0.00
$-0.10

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
EEX
EEX
PBYI
PBYI
Cash + ST InvestmentsLiquidity on hand
$100.9M
$97.5M
Total DebtLower is stronger
$22.7M
Stockholders' EquityBook value
$338.8M
$130.3M
Total Assets
$1.2B
$216.3M
Debt / EquityLower = less leverage
0.17×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
EEX
EEX
PBYI
PBYI
Q4 25
$100.9M
$97.5M
Q3 25
$95.4M
$94.4M
Q2 25
$156.4M
$96.0M
Q1 25
$276.8M
$93.2M
Q4 24
$194.8M
$101.0M
Q3 24
$188.9M
$96.7M
Q2 24
$193.2M
$96.8M
Q1 24
$186.8M
$107.2M
Total Debt
EEX
EEX
PBYI
PBYI
Q4 25
$22.7M
Q3 25
$34.0M
Q2 25
$45.3M
Q1 25
$56.7M
Q4 24
$68.0M
Q3 24
$79.3M
Q2 24
$90.7M
Q1 24
$102.0M
Stockholders' Equity
EEX
EEX
PBYI
PBYI
Q4 25
$338.8M
$130.3M
Q3 25
$369.5M
$115.3M
Q2 25
$389.4M
$104.7M
Q1 25
$392.1M
$97.1M
Q4 24
$385.9M
$92.1M
Q3 24
$391.1M
$71.1M
Q2 24
$407.6M
$48.5M
Q1 24
$-90.7M
$51.0M
Total Assets
EEX
EEX
PBYI
PBYI
Q4 25
$1.2B
$216.3M
Q3 25
$1.2B
$202.9M
Q2 25
$1.2B
$194.9M
Q1 25
$1.2B
$196.2M
Q4 24
$1.0B
$213.3M
Q3 24
$1.1B
$220.7M
Q2 24
$1.1B
$205.0M
Q1 24
$1.1B
$214.1M
Debt / Equity
EEX
EEX
PBYI
PBYI
Q4 25
0.17×
Q3 25
0.30×
Q2 25
0.43×
Q1 25
0.58×
Q4 24
0.74×
Q3 24
1.12×
Q2 24
1.87×
Q1 24
2.00×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
EEX
EEX
PBYI
PBYI
Operating Cash FlowLast quarter
$12.3M
$14.4M
Free Cash FlowOCF − Capex
$11.7M
$14.4M
FCF MarginFCF / Revenue
8.8%
19.1%
Capex IntensityCapex / Revenue
0.5%
0.0%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$41.4M
$41.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
EEX
EEX
PBYI
PBYI
Q4 25
$12.3M
$14.4M
Q3 25
$1.8M
$9.7M
Q2 25
$15.9M
$14.1M
Q1 25
$12.6M
$3.6M
Q4 24
$20.6M
$15.6M
Q3 24
$9.1M
$11.0M
Q2 24
$9.8M
$1.0M
Q1 24
$7.3M
$11.2M
Free Cash Flow
EEX
EEX
PBYI
PBYI
Q4 25
$11.7M
$14.4M
Q3 25
$1.5M
$9.7M
Q2 25
$15.8M
$14.1M
Q1 25
$12.4M
$3.6M
Q4 24
$19.9M
$15.6M
Q3 24
$9.0M
$11.0M
Q2 24
$9.6M
$1.0M
Q1 24
$7.0M
FCF Margin
EEX
EEX
PBYI
PBYI
Q4 25
8.8%
19.1%
Q3 25
1.9%
17.7%
Q2 25
15.0%
26.8%
Q1 25
8.4%
7.7%
Q4 24
18.6%
26.4%
Q3 24
12.4%
13.7%
Q2 24
11.2%
2.1%
Q1 24
5.2%
Capex Intensity
EEX
EEX
PBYI
PBYI
Q4 25
0.5%
0.0%
Q3 25
0.4%
0.0%
Q2 25
0.1%
0.0%
Q1 25
0.1%
0.1%
Q4 24
0.7%
0.0%
Q3 24
0.1%
0.0%
Q2 24
0.2%
0.0%
Q1 24
0.2%
0.0%
Cash Conversion
EEX
EEX
PBYI
PBYI
Q4 25
Q3 25
1.10×
Q2 25
2.41×
Q1 25
0.82×
1.21×
Q4 24
4.04×
Q3 24
0.54×
Q2 24
Q1 24
0.66×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

EEX
EEX

Connections Segment$121.9M92%
Commerce Segment$5.5M4%
Content$5.3M4%

PBYI
PBYI

Segment breakdown not available.

Related Comparisons